Picton Mahoney Asset Management’s AstraZeneca AZN Stock Holding History

Picton Mahoney Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.49M	Buy	13,330 +2,112	+19%	+$397K	0.02%	505
2026 Q1	$2.18M	Buy	11,218 +9,808	+696%	+$1.89M	0.02%	466
2025 Q4	$259K	Buy	+1,410	New	+$247K	﹤0.01%	786
2015 Q2	–	Sell	-3,750	Closed	-$257K	–	297
2015 Q1	$257K	Sell	3,750 -550	-13%	-$38.2K	0.01%	196
2014 Q4	$303K	Buy	4,300 +1,550	+56%	+$111K	0.01%	201
2014 Q3	$196K	Buy	+2,750	New	+$201K	0.01%	227

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Picton Mahoney Asset Management's AZN Position: Q2 2026 in Review

Picton Mahoney Asset Management increased its AstraZeneca (AZN) stake by 19% in Q2 2026, buying an estimated $397K and bringing the position to 13,330 shares worth $2.49M. The position accounts for 0.02% of the portfolio, ranked #505.

Picton Mahoney Asset Management first reported a position in AZN in Q3 2014 and has held it in 6 quarters since. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Picton Mahoney Asset Management held 13,330 shares of AstraZeneca worth $2.49M as of Q2 2026.
Picton Mahoney Asset Management bought 2,112 AstraZeneca shares in Q2 2026, an estimated $397K.
AstraZeneca made up 0.02% of Picton Mahoney Asset Management's portfolio in Q2 2026, its #505 holding.
Picton Mahoney Asset Management first reported a position in AstraZeneca in Q3 2014 and has held it in 6 quarters since.
1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.